#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15054	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2031	726.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	871	C	854	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27752	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3631	756.0	0	.	n	.	0	T695C	SNP	695	695	T	1073	1073	C	866	C,T	847,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27752	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3631	756.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1715	1715	A	923	A	904	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27752	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3631	756.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2349	2349	C	890	C	872	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27752	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3631	756.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2975	2975	T	773	T,C	760,7	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27752	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3631	756.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2423	2423	A	886	A	875	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1926	folP	852	852	100.0	folP.l15.c4.ctg.1	1581	120.9	1	SNP	p	R228S	1	.	.	682	684	AGC	980	982	AGC	209;209;210	A;G;C,A	207;206;204,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5720	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3391	166.8	1	SNP	p	S91F	0	.	.	271	273	TCC	584	586	TCC	205;205;207	T,A;C;C	200,1;199;203	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5720	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3391	166.8	1	SNP	p	D95G	0	.	.	283	285	GAC	596	598	GAC	203;197;196	G;A;C	201;194;193	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5720	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3391	166.8	1	SNP	p	D95N	0	.	.	283	285	GAC	596	598	GAC	203;197;196	G;A;C	201;194;193	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1716	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1402	121.1	0	.	p	.	0	A39T	NONSYN	115	117	GCC	460	462	ACC	178;177;173	A,C;C;C	168,2;174;170	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1716	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1402	121.1	0	.	p	.	0	R44H	NONSYN	130	132	CGC	475	477	CAC	172;172;176	C;A,C;C	169;165,1;174	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1716	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1402	121.1	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	658	660	CAC	219;221;219	C;A;C	216;213;216	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1716	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1402	121.1	1	SNP	p	G45D	0	.	.	133	135	GGC	478	480	GGC	176;176;177	G;G,T;C,A	172;173,1;174,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	942	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	910	101.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5178	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2966	173.0	1	SNP	p	D86N	0	.	.	256	258	GAC	591	593	GAC	172;174;181	G;A;C,G	171;169;179,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5178	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2966	173.0	1	SNP	p	S87R	0	.	.	259	261	AGT	594	596	AGT	187;190;191	A,G;G;T,C	180,1;185;183,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5178	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2966	173.0	1	SNP	p	S87I	0	.	.	259	261	AGT	594	596	AGT	187;190;191	A,G;G;T,C	180,1;185;183,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5178	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2966	173.0	1	SNP	p	S87W	0	.	.	259	261	AGT	594	596	AGT	187;190;191	A,G;G;T,C	180,1;185;183,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5178	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2966	173.0	1	SNP	p	S88P	0	.	.	262	264	TCC	597	599	TCC	191;191;192	T;C,T;C	187;188,1;188	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4434	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2626	166.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1516	1518	GGC	218;216;217	G;G;C	213;214;212	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3992	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2363	166.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1267	1269	GCA	216;216;221	G;C;A,C	213;212;216,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3992	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2363	166.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1270	1272	ATC	222;221;213	A;T;C,G	218;216;208,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3992	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2363	166.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1282	1284	GTG	215;215;217	G,A;T,C;G,C	210,1;210,1;215,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3992	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2363	166.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1282	1284	GTG	215;215;217	G,A;T,C;G,C	210,1;210,1;215,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3992	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2363	166.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1786	1788	ACC	162;165;166	A;C;C	156;163;161	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3992	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2363	166.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1840	1842	GCG	166;167;170	G;C,A,G;G	160;146,1,2;165	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3992	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2363	166.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1840	1842	GCG	166;167;170	G;C,A,G;G	160;146,1,2;165	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3992	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2363	166.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1963	1965	GGC	126;126;124	G;G;C,T	120;122;117,2	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3992	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2363	166.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1972	1974	GGC	114;114;113	G,A;G;C	106,2;104;107	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3992	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2363	166.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1990	1992	CCG	81;81;80	C,G;C;G	76,1;78;64	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5870	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	2953	195.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1549	1551	CTG	218;215;217	C;T;G,T	204;194;201,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2468	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1995	122.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	612	612	C	152	C	144	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2666	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1665	158.7	0	.	p	.	0	E48G	NONSYN	142	144	GAA	535	537	GGA	214;213;213	G;G;A,G	212;208;207,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2666	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1665	158.7	0	.	p	.	0	F135L	NONSYN	403	405	TTT	796	798	CTT	206;206;201	C,T;T;T	199,3;199;196	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2666	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1665	158.7	0	.	p	.	0	R143G	NONSYN	427	429	AGA	820	822	GGA	192;190;188	G,A;G,A;A	185,1;184,1;179	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2666	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1665	158.7	0	.	p	.	0	D171G	NONSYN	511	513	GAT	904	906	GGT	193;193;194	G,A;G;T	190,1;189;181	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2666	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1665	158.7	0	.	p	.	0	G189S	NONSYN	565	567	GGC	958	960	AGC	189;189;190	A,G;G;C	186,1;185;184	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2666	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1665	158.7	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1024	1024	T	170	T,C	161,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2666	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1665	158.7	1	SNP	p	G120K	0	.	.	358	360	GGT	751	753	GGT	198;196;195	G;G;T	195;193;187	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2666	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1665	158.7	1	SNP	p	A121D	0	.	.	361	363	GCC	754	756	GCC	194;195;194	G;C;C	188;193;193	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2666	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1665	158.7	1	SNP	p	A121N	0	.	.	361	363	GCC	754	756	GCC	194;195;194	G;C;C	188;193;193	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9974	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4943	199.6	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1972	1974	AAT	233;235;235	A,C;A;T	227,4;230;231	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1166	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1075	106.6	1	SNP	p	V57M	1	.	.	169	171	ATG	615	617	ATG	211;209;212	A;T;G	208;205;208	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
